Answers are grounded in this paper and cite their sources.
Analysis demonstrates enhanced accuracy in measuring ethylene glycol in human plasma, suggesting quicker diagnosis and treatment.
Background A component of antifreeze and household products, ethylene glycol, is a highly poisonous compound that is a rare but potentially fatal toxin of abuse. While few cases are documented each year, its ingestion can lead to rapidly progressive organ decline. Indirect methods of identification are not specific, and the current gold standard, gas chromatography (GC)-mass spectroscopy, causes delays due to the need to send out to specialized laboratories, resulting in diagnostic and treatment delays. Early recognition and accurate measurement highlight the need for a rapid, automated, and cost-effective assay that accounts for common interference. Here, we present an evaluation of the analytical performance of an automated enzymatic assay for measuring ethylene glycol on a Beckman DXC using a commercially available kit from Catachem and compare the performance of the assay on the DXC analyzer to the GC-mass and another enzymatic assay. Methods Method comparison was performed between ARUP and UAMS by testing 43 specimens spanning the full AMR (8-294) and evaluated for accuracy. Analytical parameters of imprecision, limit of quantitation, linearity, specimen stability at 12 and 24 hours, accuracy, and interferences associated with hemolysis, lipemia, icterus, ethanol, and lactate were studied. Human plasma samples were spiked and processed through three analytical methods: Catachem assay using the Beckman DXC platform, reference lab enzymatic assay, and reference lab gas chromatography-mass spectrometry method. Results Full AMR (8-294) linearity of the assay was proven when compared to ARUP. A gas chromatography comparison study between the UAMS enzymatic method and Mayo Clinic showed a slope of 0.790 that was outside the acceptable range however, since the assay is used as a screening test, values above the 5 mg/dL cutoff are sent to Mayo Clinic for confirmation. Inter-assay precision was appropriate, even near the positive cutoff. No significant interference were noted. No specimen stability differences were noted after 24 hours. Conclusion We compared our developed assay to gas chromatography-mass spectrometry and with another institutes. Our laboratory has started the use of the automated enzymatic assay for measuring ethylene glycol after our study. This enzymatic assay can be adapted for use in other clinical laboratories to improve diagnosis to treatment time for patients.
No takes yet. Share an insight, caveat, or question.
Rosales et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: